ABVC BioPharma, Inc. Common Stock (ABVC) is a publicly traded Healthcare sector company. As of November 2, 2026, ABVC trades at $1.02 with a market cap of $26.69M and a P/E ratio of -2.51. ABVC moved +3.50% today. Year to date, ABVC is -54.34%; over the trailing twelve months it is -64.54%. Its 52-week range spans $0.61 to $5.48. Rallies surfaces ABVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ABVC insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.02 |
| Market Cap | $26.69M |
| P/E Ratio | -2.51 |
| EPS | $-0.39 |
| Dividend Yield | 0.29% |
| 52-Week High | $5.48 |
| 52-Week Low | $0.61 |
| Volume | 5.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.38M |
| Gross Margin | 0.00% |
ABVC analyst coverage data. Average price target: $0.00.